New Approaches in the Treatment of Hepatocellular Carcinoma and Liver Tumor
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 384
Special Issue Editors
Interests: radiology; oncology
Interests: radiology
Interests: gastroiontestinal cancers; robotic surgery; surgical oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Hepatocellular carcinoma (HCC) is the most frequently observed primary malignant liver tumor and is a major cause of worldwide mortality. Despite the advent of screening programs for patients with known risk factors, a substantial number of patients are ineligible for curative surgery at presentation. Thus, locoregional treatments now hold a pivotal role in HCC management; trans-arterial chemoembolization, percutaneous ablation and more recently selective internal radiation therapy are often the first-line treatments for selected stages of HCC or serve as a bridge to liver transplantation.
The goal of this Research Topic is to provide a comprehensive overview of various image-guided minimally invasive therapies available for HCC with an assessment of novel combination regimens and future perspectives, to better investigate the role of radiology in the assessment of responses to locoregional treatments for HCC. We welcome you to submit basic and clinical research articles and reviews.
Dr. Riccardo Inchingolo
Dr. Stavros Spiliopoulos
Dr. Riccardo Memeo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatocellular carcinoma
- cirrhosis
- liver
- interventional oncology
- trans-arterial chemo embolization
- selective internal radiation therapy
- ablation
- radiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
